Methods and apparatuses (e.g., systems, devices, etc.) for delivering a nebulized drug agent in the nasal passages concurrent with the lungs.

A pulmonary drug delivery system is disclosed, including a breath-powered, dry powder inhaler, with or without a cartridge for delivering a dry powder formulation. The inhaler and cartridge can be provided with a drug delivery formulation comprising, for example, a diketopiperazine and an active ingredient, including, small organic molecules, peptides and proteins, including, hormones such as insulin and glucagon-like peptide 1 for the treatment of disease and disorders, for example, diseases and disorders, including endocrine disease such as diabetes and/or obesity.

There is provided an aerosol generating system, the system comprising: aerosol generating means; aerosol delivery means; and an aerosol guiding device (1). The aerosol guiding device comprises a chamber having an air inlet (14) and an air outlet (12) and the aerosol delivery means is configured such that aerosol is introduced from the aerosol generating means into the chamber in use. An airflow route is defined from the air inlet to the air outlet so as to convey the aerosol to the air outlet, and the relative dimensions of the air inlet and the air outlet are selected to provide pressure control means for controlling the pressure differential between the air inlet and the air outlet. There is also provided an aerosol guiding device for use in an aerosol generating system, the device comprising: a chamber having an air inlet and an air outlet. Aerosol is introduced from an aerosol generating means into the chamber in use, an airflow route is defined from the air inlet to the air outlet so as to convey the aerosol to the air outlet, and the relative dimensions of the air inlet and the air outlet are selected to provide pressure control means for controlling the pressure differential between the air inlet and the air outlet.

A graphene nano-steam generator and a beauty instrument are provided. The graphene nano-steam generator includes a coarse steam channel, a nano-steam channel and a high-voltage power supply device. The coarse steam channel is connected to a coarse steam manufacturing device and the nano-steam channel. The coarse steam channel is provided with a steam sieving device, and an end of the coarse steam channel is provided with a first electrode and a second electrode. The high-voltage power supply device is coupled to the first electrode and the second electrode. The high-voltage power supply device supplies high-voltage electricity to the first electrode and the second electrode, and forms a high-voltage arc discharge between the first electrode and the second electrode, thus the coarse steam molecular group flowing through is ionized by the high-voltage arc to generate a large amount of active nano-scale steam to be flowed out from the nano-steam channel.

The present invention provides for a method for the treatment of a respiratory disease, disorder or condition, or a viral infection or viral disease, disorder or condition in a subject, the method comprising the step of administering to said subject a medically active liquid in nebulized form by inhalation, wherein the medically active liquid comprises niclosamide or a pharmaceutically acceptable salt thereof and wherein the medically active liquid is administered in nebulized form using an inhalation device.

A droplet delivery device with an ejector mechanism and fluid reservoir includes an accelerometer to determine and communicate optimized mixing of fluid in the reservoir for inhalation of droplets, such as into the lungs, from the droplet delivery device.

An optimization methodology is employed to match vibratory inhaler devices having certain characteristics to the particular anatomical and acoustic properties of a patient's vocal tract, in order to achieve the most effective dispersion of a dry powder medicament using inspiratory effort of a user of the inhaler. In embodiments, optimization involves employing one or more measurements of acoustic frequency spectrum properties as well as one or more anatomical/geometric measurements of the structures comprising the particular patient's mouth, pharynx, and upper respiratory tract and matching a vibratory inhalation device that corresponds thereto.

A system for delivering a composition containing a nutritional supplement matrix to a user through the oral mucosa, in which the matrix is held under pressure in a canister that has a nozzle with at least one rotating internal member positioned between the canister outlet and the nozzle outlet, in which the rotating member agitates the composition to increase atomization to aid in absorption.

Disclosed is an oral mucosa delivery system that allows a composition housed therein to be dispensed in different amount and/or for different duration. The delivery system may comprise a spray cap or an aerosol cap capable of controlling the delivery duration and/or amount by a mechanical or electronic means.

A nebuliser for nebulising liquid droplets, including: a housing; at least one piezoelectric substrate (2) accommodated within the housing and having a transducer surface (2a) upon which is located at least one electroacoustic transducer (48) for generating acoustic wave energy within the at least one piezoelectric substrate (2), and an opposing non-transducer surface (2b); a liquid supply system for supplying a liquid to at least one of the transducer and non-transducer surfaces, the liquid supply system including a reservoir (3) for accommodating the liquid, and at least one relatively rigid supply conduit in contact with the at least one piezoelectric substrate (2) for supplying the liquid from the reservoir (3) to the at least one piezoelectric substrate (2); and a sensor for detecting a volume of liquid on the at least one piezoelectric substrate (2).